Home › NDC Lookup › RxCUI directory › RxCUI 795085

Certolizumab pegol 200 MG Injection [Cimzia] — RxCUI 795085

Name: Certolizumab pegol 200 MG Injection [Cimzia] (RxCUI 795085)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 795085 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI795085

Official nameCertolizumab pegol 200 MG Injection [Cimzia]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asCimzia 200 MG Injection

FDA products mapped3

Package NDCs mapped6

Reported Medicaid activity (SDUD)32,049 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Certolizumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Cimzia is used to treat several inflammatory conditions driven by an overactive immune protein called TNFα. In adults, it can be used for Crohn's disease, rheumatoid arthritis, pso...
Cimzia comes as a prefilled syringe that you inject under the skin — usually into your thigh or abdomen — after getting trained by your healthcare provider. Take it out of the frid...
How do I give myself this injection, and does it hurt?
The biggest concern with Cimzia is serious infections — including tuberculosis, fungal infections, and bacterial infections. Call your doctor right away if you develop a fever, chi...

📖 Read our full Certolizumab Injection guide →

🕸️ Concept Web — How Certolizumab pegol 200 MG Injection [Cimzia] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Certolizumab pegol 200 MG Injection [Cimzia] RxCUI 795085 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Certolizumab pegol 709271 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Cimzia 795082 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Certolizumab pegol Injection 1653728 SCDF
- Certolizumab pegol Injectable Product 1161226 SCDG
- Certolizumab pegol Injection [Cimzia] 1653731 SBDF
- Cimzia Injectable Product 1170885 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Certolizumab pegol 200 MG Injection 795081 SCD
- Certolizumab pegol 200 MG 1653727 SCDC
- Certolizumab pegol 200 MG [Cimzia] 1653730 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Certolizumab pegol 200 MG Injection SCD · 795081
Certolizumab pegol 200 MG SCDC · 1653727
Certolizumab pegol Injection SCDF · 1653728
Certolizumab pegol Injectable Product SCDG · 1161226

Brand-Name Concepts

Certolizumab pegol 200 MG [Cimzia] SBDC · 1653730
Certolizumab pegol Injection [Cimzia] SBDF · 1653731
Cimzia Injectable Product SBDG · 1170885
Cimzia BN · 795082

📦 FDA Products & Package NDCs

3 products · 6 package NDCs

6 package NDCs map to RxCUI 795085 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
50474-0700-61	2 KIT in 1 CARTON (50474-700-61) / 1 KIT in 1 KIT * 1 mL i...	Cimzia	UCB, Inc.	2008-04-20
50474-0700-62	2 KIT in 1 CARTON (50474-700-62) / 1 KIT in 1 KIT * 1 mL i...	Cimzia	UCB, Inc.	2008-04-20
50474-0710-79	2 SYRINGE, GLASS in 1 CARTON (50474-710-79) / 1 mL in 1 SYR...	Cimzia	UCB, Inc.	2009-05-14
50474-0710-80	2 SYRINGE, GLASS in 1 CARTON (50474-710-80) / 1 mL in 1 SYR...	Cimzia	UCB, Inc.	2009-05-14
50474-0710-81	3 CARTON in 1 BOX (50474-710-81) / 2 SYRINGE, GLASS in 1 CA...	Cimzia	UCB, Inc.	2009-05-14
50474-0750-10	1 SYRINGE, GLASS in 1 CARTON (50474-750-10) / 1 mL in 1 SYR...	Cimzia	UCB, Inc.	2025-03-01

Observed labelers: UCB, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0717	Certolizumab pegol inj 1mg	4	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.